Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Assets (2016 - 2025)

Neuroone Medical Technologies' Return on Assets history spans 11 years, with the latest figure at 0.71% for Q4 2025.

  • For Q4 2025, Return on Assets rose 51.0% year-over-year to 0.71%; the TTM value through Dec 2025 reached 0.71%, up 51.0%, while the annual FY2025 figure was 0.45%, 138.0% up from the prior year.
  • Return on Assets reached 0.71% in Q4 2025 per NMTC's latest filing, down from 0.33% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.33% in Q3 2025 to a low of 2.4% in Q3 2024.
  • Average Return on Assets over 5 years is 1.2%, with a median of 1.0% recorded in 2022.
  • Peak YoY movement for Return on Assets: crashed -117bps in 2024, then surged 206bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.86% in 2021, then grew by 8bps to 0.79% in 2022, then tumbled by -144bps to 1.94% in 2023, then surged by 37bps to 1.21% in 2024, then skyrocketed by 42bps to 0.71% in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Return on Assets are 0.71% (Q4 2025), 0.33% (Q3 2025), and 0.7% (Q2 2025).